Small Efficient Cell-penetrating Peptides Derived from Scorpion Toxin Maurocalcine

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2012 Mar 22

PMID 22433862

Citations 8

Authors

Cathy Poillot

Hicham Bichraoui

Celine Tisseyre

Eloi Bahemberae

Nicolas Andreotti

Jean-Marc Sabatier

Michel Ronjat

Michel De Waard

Affiliations

Soon will be listed here.

Abstract

Maurocalcine is the first demonstrated example of an animal toxin peptide with efficient cell penetration properties. Although it is a highly competitive cell-penetrating peptide (CPP), its relatively large size of 33 amino acids and the presence of three internal disulfide bridges may hamper its development for in vitro and in vivo applications. Here, we demonstrate that several efficient CPPs can be derived from maurocalcine by replacing Cys residues by isosteric 2-aminobutyric acid residues and sequence truncation down to peptides of up to 9 residues in length. A surprising finding is that all of the truncated maurocalcine analogues possessed cell penetration properties, indicating that the maurocalcine is a highly specialized CPP. Careful examination of the cell penetration properties of the truncated analogues indicates that several maurocalcine-derived peptides should be of great interest for cell delivery applications where peptide size matters.

Citing Articles

Cryo-EM analysis of scorpion toxin binding to Ryanodine Receptors reveals subconductance that is abolished by PKA phosphorylation.

Haji-Ghassemi O, Chen Y, Woll K, Gurrola G, Valdivia C, Cai W Sci Adv. 2023; 9(21):eadf4936.

PMID: 37224245 PMC: 10208580. DOI: 10.1126/sciadv.adf4936.

Cell-Penetrating Peptides Derived from Animal Venoms and Toxins.

Radis-Baptista G Toxins (Basel). 2021; 13(2).

PMID: 33671927 PMC: 7919042. DOI: 10.3390/toxins13020147.

Discovery and Characterization of Peptide Inhibitors for Calcium and Integrin Binding Protein 1.

Puhl A, Bogart J, Haberman V, Larson J, Godoy A, Norris-Drouin J ACS Chem Biol. 2020; 15(6):1505-1516.

PMID: 32383857 PMC: 7305997. DOI: 10.1021/acschembio.0c00144.

CPP-Ts: a new intracellular calcium channel modulator and a promising tool for drug delivery in cancer cells.

Oliveira-Mendes B, Horta C, do Carmo A, Biscoto G, Sales-Medina D, Leal H Sci Rep. 2018; 8(1):14739.

PMID: 30282983 PMC: 6170434. DOI: 10.1038/s41598-018-33133-3.

Cell-penetrating peptides derived from TcdB2 and a related large clostridial toxin.

Larabee J, Hauck G, Ballard J J Biol Chem. 2017; 293(5):1810-1819.

PMID: 29247010 PMC: 5798309. DOI: 10.1074/jbc.M117.815373.

References

Aroui S, Brahim S, De Waard M, Kenani A . Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study. Biochem Biophys Res Commun. 2009; 391(1):419-25. DOI: 10.1016/j.bbrc.2009.11.073. View

Chen L, Esteve E, Sabatier J, Ronjat M, De Waard M, Allen P . Maurocalcine and peptide A stabilize distinct subconductance states of ryanodine receptor type 1, revealing a proportional gating mechanism. J Biol Chem. 2003; 278(18):16095-106. DOI: 10.1074/jbc.M209501200. View

Szappanos H, Smida-Rezgui S, Cseri J, Simut C, Sabatier J, De Waard M . Differential effects of maurocalcine on Ca2+ release events and depolarization-induced Ca2+ release in rat skeletal muscle. J Physiol. 2005; 565(Pt 3):843-53. PMC: 1464547. DOI: 10.1113/jphysiol.2005.086074. View

Meier O, Boucke K, Hammer S, Keller S, Stidwill R, Hemmi S . Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J Cell Biol. 2002; 158(6):1119-31. PMC: 2173207. DOI: 10.1083/jcb.200112067. View

Ram N, Weiss N, Texier-Nogues I, Aroui S, Andreotti N, Pirollet F . Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells. J Biol Chem. 2008; 283(40):27048-56. PMC: 2652642. DOI: 10.1074/jbc.M804727200. View

Fajloun Z, Kharrat R, Chen L, Lecomte C, Di Luccio E, Bichet D . Chemical synthesis and characterization of maurocalcine, a scorpion toxin that activates Ca(2+) release channel/ryanodine receptors. FEBS Lett. 2000; 469(2-3):179-85. DOI: 10.1016/s0014-5793(00)01239-4. View

West M, BRETSCHER M, Watts C . Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J Cell Biol. 1989; 109(6 Pt 1):2731-9. PMC: 2115909. DOI: 10.1083/jcb.109.6.2731. View

Poillot C, Dridi K, Bichraoui H, Pecher J, Alphonse S, Douzi B . D-Maurocalcine, a pharmacologically inert efficient cell-penetrating peptide analogue. J Biol Chem. 2010; 285(44):34168-80. PMC: 2962515. DOI: 10.1074/jbc.M110.104919. View

Ram N, Aroui S, Jaumain E, Bichraoui H, Mabrouk K, Ronjat M . Direct peptide interaction with surface glycosaminoglycans contributes to the cell penetration of maurocalcine. J Biol Chem. 2008; 283(35):24274-84. PMC: 2701444. DOI: 10.1074/jbc.M709971200. View

10.

Esteve E, Smida-Rezgui S, Sarkozi S, Szegedi C, Regaya I, Chen L . Critical amino acid residues determine the binding affinity and the Ca2+ release efficacy of maurocalcine in skeletal muscle cells. J Biol Chem. 2003; 278(39):37822-31. DOI: 10.1074/jbc.M305798200. View

11.

Aroui S, Brahim S, Hamelin J, De Waard M, Breard J, Kenani A . Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis. Apoptosis. 2009; 14(11):1352-65. DOI: 10.1007/s10495-009-0397-8. View

12.

Pouvreau S, Csernoch L, Allard B, Sabatier J, De Waard M, Ronjat M . Transient loss of voltage control of Ca2+ release in the presence of maurocalcine in skeletal muscle. Biophys J. 2006; 91(6):2206-15. PMC: 1557560. DOI: 10.1529/biophysj.105.078089. View

13.

Gurrola G, Arevalo C, Sreekumar R, Lokuta A, Walker J, Valdivia H . Activation of ryanodine receptors by imperatoxin A and a peptide segment of the II-III loop of the dihydropyridine receptor. J Biol Chem. 1999; 274(12):7879-86. DOI: 10.1074/jbc.274.12.7879. View

14.

Aroui S, Ram N, Appaix F, Ronjat M, Kenani A, Pirollet F . Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231. Pharm Res. 2008; 26(4):836-45. PMC: 2820506. DOI: 10.1007/s11095-008-9782-1. View

15.

Mosbah A, Kharrat R, Fajloun Z, Renisio J, Blanc E, Sabatier J . A new fold in the scorpion toxin family, associated with an activity on a ryanodine-sensitive calcium channel. Proteins. 2000; 40(3):436-42. DOI: 10.1002/1097-0134(20000815)40:3<436::aid-prot90>3.0.co;2-9. View

16.

Mabrouk K, Ram N, Boisseau S, Strappazzon F, Rehaim A, Sadoul R . Critical amino acid residues of maurocalcine involved in pharmacology, lipid interaction and cell penetration. Biochim Biophys Acta. 2007; 1768(10):2528-40. DOI: 10.1016/j.bbamem.2007.06.030. View

17.

MERRIFIELD R . Solid-phase peptide synthesis. Adv Enzymol Relat Areas Mol Biol. 1969; 32:221-96. DOI: 10.1002/9780470122778.ch6. View

18.

Esteve E, Mabrouk K, Dupuis A, Smida-Rezgui S, Altafaj X, Grunwald D . Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane. J Biol Chem. 2005; 280(13):12833-9. PMC: 2713311. DOI: 10.1074/jbc.M412521200. View

19.

Kim D, Ohnishi S, Ikemoto N . Kinetic studies of calcium release from sarcoplasmic reticulum in vitro. J Biol Chem. 1983; 258(16):9662-8. View

20.

Aroui S, Brahim S, De Waard M, Breard J, Kenani A . Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231. Cancer Lett. 2009; 285(1):28-38. DOI: 10.1016/j.canlet.2009.04.044. View